Q&A: Ashkan Abbey shares details from DAVIO-2 trial at AAO 2025ByAshkan Abbey, MD, FASRS, FAAO,Sydney M CragoNovember 6th 2025Data suggests that EYP-1901 can reduce the number of injections and treatment burden for patients